SCHEMBL30006720

SCHEMBL30006720

Cn1ncc2ccc(CC(N)=O)cc21

nearest known ligand 0.48

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
PDE1C Q14123 1/20 0.48
CACNA1H O95180 10/20 0.47
CCNC P24863 1/20 0.46
CDK8 P49336 1/20 0.46
MET P08581 1/20 0.45
MST1R Q04912 1/20 0.45
MPO P05164 1/20 0.44
KDM2B Q8NHM5 1/20 0.44
KDM4C Q9H3R0 1/20 0.44
KMO O15229 1/20 0.43
ERCC1 P07992 1/20 0.43
ERCC4 Q92889 1/20 0.43
VNN1 O95497 1/20 0.43
KDM4E B2RXH2 1/20 0.43
LMNA P02545 1/20 0.43
POLB P06746 1/20 0.43
MAPK1 P28482 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30006677 0.89 CACNA1H (0.55) CACNA1HCCNCCDK8METMPO
SCHEMBL17316406 0.86 KDM4E (0.53) CACNA1HCCNCCDK8KDM2BKDM4C
SCHEMBL17316500 0.79 CACNA1H (0.46) PDE1CCACNA1HCCNCCDK8MPO
SCHEMBL29585470 0.78 MPO (0.49) PDE1CCACNA1HCCNCCDK8MPO
SCHEMBL904805 0.78 MPO (0.49) PDE1CCACNA1HCCNCCDK8MPO
SCHEMBL14800197 0.78 NOTUM (0.52) PDE1CCACNA1HCCNCCDK8MPO
SCHEMBL30903411 0.78 NOTUM (0.52) PDE1CCACNA1HCCNCCDK8MPO
SCHEMBL19691125 0.78 AR (0.55) PDE1CCCNCCDK8ERCC1ERCC4
SCHEMBL29503149 0.78 AR (0.55) PDE1CCCNCCDK8ERCC1ERCC4
SCHEMBL8172855 0.76 MPO (0.47) PDE1CCACNA1HCCNCCDK8MPO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4337642-A1 ETHACRYNIC ACID DERIVATIVES AS INHIBITORS OF MPRO PROTEASE AND SARS-COV-2 REPLICATION Universite Euro-Mediterraneenne de Fes (MA) 2024-03-20 EP disclosed
WO-2022240277-A1 ETHACRYNIC ACID DERIVATIVES AS INHIBITORS OF MPRO PROTEASE AND SARS-COV-2 REPLICATION UNIVERSITE EURO-MEDITERRANEENNE DE FES (MA) 2022-11-17 WO disclosed